Catalyst Wire Dossier Catalyst Wire Dossier

Inaxaplin

inaxaplin · Vertex Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Inaxaplin, covering 2024-07-12 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities [Phase 2]

See pricing